Table 3.
Feature of the patients at last follow-up visit
| Variables | Value |
|---|---|
| Follow-up time (mo) | 10.55 ± 5.05 |
| BMI (kg/m2) | 33.87 ± 8.43 |
| SBP (mm Hg) | 137.16 ± 20.08 |
| DBP (mm Hg) | 75.05 ± 11.77 |
| eGFR (ml/min per 1.73 m2) | 24.98 ± 15.55 |
| eGFR change (%), median (IQR) | -18.26 (45) |
| eGFR change (%/y), median (IQR) | -25.84 (58) |
| UPCR (mg/g), median (IQR) | 5010 (8260) |
| UPCR fold change, median (IQR) | 0.94 (1.31) |
| UPCR fold change (/y), median (IQR) | 1.29 (2.15) |
| ESKD progression, n (%) | 17 (27.4) |
BMI, body mass index; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; ESKD, end-stage kidney disease; IQR, interquartile range; SBP, systolic blood pressure; UPCR, urine protein to creatinine ratio.